Accuray (ARAY) Gains from Investment Securities (2018 - 2026)
Accuray's (ARAY) quarterly Gains from Investment Securities came in at -$3.4 million in Q1 2026, up 41.2% quarter-over-quarter from -$5.7 million in Q4 2025.
Accuray (ARAY) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Accuray's Gains from Investment Securities history runs 3 years deep, the most recent figure standing at -$3.4 million for Q1 2026.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$7.2 million, a 7757.45% decrease from a year earlier, with the FY2025 full-year figure at $499000.0, changed N/A from the prior year.
- Gains from Investment Securities improved to -$3.4 million in Q1 2026 per ARAY's latest filing, from -$5.7 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.9 million in Q3 2025 and bottomed at -$5.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn |
| 10 | Accuray | 28,055.41 | -38.51 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.36 Mn |
| Mar 31, 2026 | -3.36 Mn |
| Dec 31, 2025 | -5.71 Mn |
| Dec 31, 2025 | -5.71 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2018 | 94,000.00 |
| Jun 30, 2018 | 94,000.00 |